Recommendations for the Clinical Development of Medicinal Products for Non-specific Influenza Chemoprophylaxis
INTRODUCTION. The evolution of the influenza virus has led to a gradual decrease in the effectiveness of current antivirals. Better methods of prevention, detection, control, and treatment of influenza are needed, including more effective vaccines and antivirals. At the moment, the Russian Federatio...
Main Authors: | A. I. Gubenko, O. Yu. Ivanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
NEICON ISP LLC
2024-04-01
|
Series: | Ведомости Научного центра экспертизы средств медицинского применения |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/581 |
Similar Items
-
Recommendations for the programme of clinical trials of medicinal products for the treatment of influenza
by: A. I. Gubenko, et al.
Published: (2023-12-01) -
Effectiveness and safety of isoniazid chemoprophylaxis for HIV-1 infected patients from Rio de Janeiro
by: Claudia Teresa Vieira de Souza, et al.
Published: (2009-05-01) -
Clinical Advances in Viral-Vectored Influenza Vaccines
by: Sarah Sebastian, et al.
Published: (2018-05-01) -
Quadrivalent inactivated influenza vaccine (VaxigripTetra™)
by: Viviane Gresset-Bourgeois, et al.
Published: (2018-01-01) -
Etiotropic therapy and chemoprophylaxis of influenza with neuraminidase inhibitors
by: T. G. Zubkova, et al.
Published: (2020-01-01)